16-bromoepiandrosterone has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dowding, C; Frincke, J; Garsd, A; Onizuka-Handa, N; Reading, C; Schramm, B; Stickney, D | 1 |
1 trial(s) available for 16-bromoepiandrosterone and HIV Coinfection
Article | Year |
---|---|
Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
Topics: Adult; Androsterone; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cell Count; Cyclooxygenase 2; Dendritic Cells; Double-Blind Method; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Injections, Subcutaneous; Interleukin-1; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Killer Cells, Natural; Lectins, C-Type; Leukocyte Count; Leukocytes, Mononuclear; Male; Membrane Proteins; Reagent Kits, Diagnostic; RNA, Messenger; T-Lymphocytes; Treatment Outcome; Tumor Necrosis Factor-alpha; Viral Load | 2006 |